This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2004
Title: Reija Valtola: Innovator in Tumor Imaging and Therapy
Introduction
Reija Valtola is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of tumor imaging and anti-tumor therapy. Her innovative work focuses on the Flt4 receptor tyrosine kinase, which plays a crucial role in cancer research.
Latest Patents
Reija Valtola holds a patent for her invention titled "Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy." This patent includes purified Flt4 receptor tyrosine kinase polypeptides and fragments, polynucleotides encoding these polypeptides, and antibodies that specifically bind to them. The applications of her invention are vital for advancing cancer treatment and diagnostics.
Career Highlights
Throughout her career, Reija has demonstrated a strong commitment to research and innovation. Her work has led to the development of new therapeutic strategies that enhance the effectiveness of cancer treatments. She is recognized for her expertise and contributions to the scientific community.
Collaborations
Reija has collaborated with notable researchers in her field, including Kari Alitalo and Arja Kaipainen. These partnerships have furthered her research and expanded the impact of her inventions.
Conclusion
Reija Valtola is a trailblazer in the realm of tumor imaging and therapy, with her innovative patent paving the way for future advancements in cancer treatment. Her contributions are invaluable to the scientific community and the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile